Lindsay Rosenwald

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (May 2013) (Learn how and when to remove this message) This article is an autobiography or has been extensively edited by the subject or by someone connected to the subject. It may need editing to conform to Wikipedia's neutral point of view policy. There may be relevant discussion on the talk page. (May 2013) (Learn how and when to remove this message) This article may be written from a fan's point of view, rather than a neutral point of view. Please clean it up to conform to a higher standard of quality, and to make it neutral in tone. (May 2013) (Learn how and when to remove this message) This article may lend undue weight to certain ideas, incidents, or controversies. Please help improve it by rewriting it in a balanced fashion that contextualizes different points of view. (May 2013) (Learn how and when to remove this message) (Learn how and when to remove this message)

Lindsay A. Rosenwald is an American doctor, biotechnology and life sciences industry investor.^[1] He is the co-founder of the healthcare private equity firm Opus Point Partners.^[2] Rosenwald has created and sold several biotechnological companies. In 2013 he established Fortress Biotech.^[3]

Medicines his companies developed have been approved by the United States Food and Drug Administration as well as in foreign countries, such as Mexico or Canada. One medicine was approved for acute promyelocytic leukemia, a routinely fatal disease. This medicine has cured many thousands of incurable patients over the last decade, marking a significant change to how this disease is treated. One of his start-ups also developed a prostate cancer medicine. That company acquired $1 billion after Phase 2 studies.^[4] Other approved medicines include meds for schizophrenia, fibromyalgia, obesity, influenza, and infant respiratory distress syndrome.